HIV-1 reverse transcriptase inhibitors
Benzophenone Derivatives: a Novel Scaffold as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
9
2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors
7
Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment)
13
Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mouse
5
MOLECULAR DOCKING STUDIES OF A FEW NOVEL PYRIMIDINE DERIVATIVES AS REVERSE TRANSCRIPTASE HIV 1 INHIBITORS
6
Comparative Analysis of Two Commercial Phenotypic Assays for Drug Susceptibility Testing of Human Immunodeficiency Virus Type 1
5
Molecular Modeling of Potential Dual Inhibitors of HIV Reverse Transcriptase and Integrase
41
HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT1t49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors
10
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.
6
Evolving uses of oral reverse transcriptase inhibitors in the HIV 1 epidemic: from treatment to prevention
9
Inhibitory activity of 9 phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV 1 as non nucleoside reverse transcriptase inhibitors
6
CURRENT STATUS OF HIV-1 INTEGRASE INHIBITORS
14
RP UFLC METHOD DEVELOPMENT AND VALIDATION FOR NEVIRAPINE IN BULK DRUG AND DOSAGE FORMS AS AN ANTIHIV AGENT
11
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase
26
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
6
Virtual Screening for Novel HIV-Reverse Transcriptase Inhibitors
5
AN INSIGHT TO STRUCTURAL ANALYSIS OF COUMARINS AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
18
Impact of Y181C and/or H221Y mutation patterns of HIV 1 reverse transcriptase on phenotypic resistance to available non nucleoside and nucleoside inhibitors in China
7
Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites
5
HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors
10